HomeACRV • NASDAQ
add
Acrivon Therapeutics Inc
Previous close
$6.44
Day range
$6.33 - $6.63
Year range
$3.19 - $11.90
Market cap
202.87M USD
Avg Volume
51.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.14M | 55.79% |
Net income | -22.44M | -55.13% |
Net profit margin | — | — |
Earnings per share | -0.59 | 10.61% |
EBITDA | -24.89M | -55.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 187.45M | 31.93% |
Total assets | 214.68M | 42.09% |
Total liabilities | 17.79M | 37.46% |
Total equity | 196.89M | — |
Shares outstanding | 31.14M | — |
Price to book | 1.02 | — |
Return on assets | -28.23% | — |
Return on capital | -29.84% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -22.44M | -55.13% |
Cash from operations | -17.32M | -76.66% |
Cash from investing | 16.01M | 956.13% |
Cash from financing | -1.50M | -2,028.21% |
Net change in cash | -2.82M | 65.71% |
Free cash flow | -9.02M | -98.62% |
About
Founded
2018
Headquarters
Website
Employees
60
